Skip to main content
OpenTrials
Completed

NCT Number: NCT01219972

Pulmonary Complications of Allografts

This is a prognostic study of the late lung complications arising at the patient's having received an allograft of hematopoetic stem cells.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Saint Louis

Paris, 75010, France

About this study

  • Objectives To estimate the incidence of late (at least occurring 100 days after transplantation) pulmonary complications following allogeneic blood stem cells transplantation
  • Study Design Prospective Cohort Study All follow-up data were actualiized in September, 2016.
  • Sample Size 200 transplanted patients
  • Main Endpoint Non infectious pulmonary complications within the first 3 years

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Allogeneic Blood stem cell transplantation
  • Alive at day 100 post-transplant

Exclusion criteria

  • Non informed consent

Treatment and study plan

Primary outcomes

  1. Non infectious pulmonary complication

    Time frame: 3 years

Secondary outcomes

  1. Survival after non infectious pulmonary complication

    Time frame: 3 years and 10 years

  2. Overall survival

    Time frame: 3 years and 10 years

  3. Long term time course of Pulmonary Function Tests (PFTs)

    Time frame: 3 years and 10 years

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Registry information

Official study title

Prospective Cohort Study of Late Pulmonary Complications in Patients Who Received Allogeneic Hematopoietic Stem Cells Transplantation: Estimation of Incidence and Identification of Distinct Nosologic Entities

Acronym: ALLOPULM

Important dates

Study start
2006
Primary completion
2009
Study completion
2016
First posted
Oct 13, 2010
Registry last updated
Jan 4, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.